Lawrence, Massachusetts-based Nexcelom Bioscience, a provider of cell counting and analysis products for biomedical research and the biopharma industry, has secured an undisclosed amount of funding. The investor was Ampersand Capital Partners.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
19 hours ago · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
30 October 2026 · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
30 October 2026 · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
30 October 2026 · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
30 October 2026 · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
30 October 2026 · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
